Can You Pass the (Deoxyribonucleic) Acid Test?
By Center for Environmental Health,
Center for Environmental Health [with CGS's Pete Shanks]
| 03. 17. 2014
For just $99, genetic test company 23andme offered to test your DNA for everything from heart disease risk to your chance of going bald. Kira Peikoff wondered what DNA testing from 23andme and two other companies would tell her—and the results were surprising. We’ll also talk to geneticist Dr. David Ng. His story in McSweeny’s, “Congratulations, Your Ineffectual Genetic Test Results Have Arrived” pokes fun at the “direct-to-consumer” genetic testing industry. Then Dr. Stuart Newman fills us in on epigenetics, evolutionary developmental biology, and why the Lamarck versus Darwin debate may be old news. Finally, advocate Pete Shanks on the “promise” of GMO humans and the threat of techno-eugenics.
Check out this episode.
Download here, or subscribe via iTunes.
Kira Peikoff is an author and Masters student in bioethics at Columbia University. Her New York Times article in December exposed the fallacies of direct-to-consumer genetic testing (see more resources on genetic test companies below). Check out her debut novel Living Proof (and look for her upcoming 2nd novel in the fall) on her website.
David Ng is...
Related Articles
By Emily Baumgaertner Nunn, The New York Times | 06.30.2026
A research program at the National Institutes of Health released the world’s largest database of human genomes and paired them with clinical data, officials announced Tuesday, paving the way for a new era of study in personalized medicine.
The All...
By Editorial Staff, The Guardian | 07.05.2026
Ever since Crispr-Cas9 gene-editing technology emerged in the early 2010s, ethical questions around genetically altered humans, so-called designer babies, have become increasingly urgent. There is already a worldwide legal prohibition. No country currently allows human germline editing (meaning genetic changes...
By Sarah Norcross, Sandy Starr, Amanda Cooney, and Anneliese Burton, BioNews | 07.06.2026
By Anna Louie Sussman, The New York Times | 07.01.2026
Birthrates in much of the developed world are at record lows, but there’s one demographic group that’s exploring new frontiers of fertility: ultrawealthy men. Deploying nearly limitless resources, a small number of them are reproducing at such an extraordinary scale...